MeSH Review:
Esophagectomy
Oberg,
Johansson,
Wenner,
Walther,
Saad,
El-Gohary,
Memari,
Liu,
Silverman,
Ren,
Law,
Huang,
Lee,
Bacher,
Srivastava,
Wong,
Hironaka,
Ohtsu,
Boku,
Muto,
Nagashima,
Saito,
Yoshida,
Nishimura,
Haruno,
Ishikura,
Ogino,
Yamamoto,
Ochiai,
Heath,
Burtness,
Heitmiller,
Salem,
Kleinberg,
Knisely,
Yang,
Talamini,
Kaufman,
Canto,
Topazian,
Wu,
Olukayode,
Forastiere,
Coia,
Minsky,
Berkey,
John,
Haller,
Landry,
Pisansky,
Willett,
Hoffman,
Owen,
Hanks,
- Perioperative granulocyte colony-stimulating factor does not prevent severe infections in patients undergoing esophagectomy for esophageal cancer: a randomized placebo-controlled clinical trial. Schaefer, H., Engert, A., Grass, G., Mansmann, G., Wassmer, G., Hubel, K., Loehlein, D., Ulrich, B.C., Lippert, H., Knoefel, W.T., Hoelscher, A.H. Ann. Surg. (2004)
- Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Heitmiller, R.F., Redmond, M., Hamilton, S.R. Ann. Surg. (1996)
- Resection margin for squamous cell carcinoma of the esophagus. Tsutsui, S., Kuwano, H., Watanabe, M., Kitamura, M., Sugimachi, K. Ann. Surg. (1995)
- Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies. Algan, O., Coia, L.R., Keller, S.M., Engstrom, P.F., Weiner, L.M., Schultheiss, T.E., Hanks, G.E. Int. J. Radiat. Oncol. Biol. Phys. (1995)
- Esophageal carcinoma metastatic to the brain: clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy. Gabrielsen, T.O., Eldevik, O.P., Orringer, M.B., Marshall, B.L. AJNR. American journal of neuroradiology. (1995)
- Gastropyloric motor activity and the effects of erythromycin given orally after esophagectomy. Nakabayashi, T., Mochiki, E., Garcia, M., Haga, N., Kato, H., Suzuki, T., Asao, T., Kuwano, H. Am. J. Surg. (2002)
- Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Vazquez-Sequeiros, E., Wang, L., Burgart, L., Harmsen, W., Zinsmeister, A., Allen, M., Jondal, M., Wiersema, M. Gastroenterology (2002)
- Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. Heath, E.I., Burtness, B.A., Heitmiller, R.F., Salem, R., Kleinberg, L., Knisely, J.P., Yang, S.C., Talamini, M.A., Kaufman, H.S., Canto, M.I., Topazian, M., Wu, T.T., Olukayode, K., Forastiere, A.A. J. Clin. Oncol. (2000)
- Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. Coia, L.R., Minsky, B.D., Berkey, B.A., John, M.J., Haller, D., Landry, J., Pisansky, T.M., Willett, C.G., Hoffman, J.P., Owen, J.B., Hanks, G.E. J. Clin. Oncol. (2000)
- Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ren, Y., Law, S., Huang, X., Lee, P.Y., Bacher, M., Srivastava, G., Wong, J. Ann. Surg. (2005)
- High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Xi, H., Baldus, S.E., Warnecke-Eberz, U., Brabender, J., Neiss, S., Metzger, R., Ling, F.C., Dienes, H.P., Bollschweiler, E., Moenig, S., Mueller, R.P., Hoelscher, A.H., Schneider, P.M. Clin. Cancer Res. (2005)
- Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy. Sauter, E.R., Coia, L.R., Eisenberg, B.L., Hanks, G.E. Int. J. Radiat. Oncol. Biol. Phys. (1995)
- Acid and duodenogastroesophageal reflux after esophagectomy with gastric tube reconstruction. Yuasa, N., Sasaki, E., Ikeyama, T., Miyake, H., Nimura, Y. Am. J. Gastroenterol. (2005)
- Functioning of the intrathoracic stomach after esophagectomy. Nishikawa, M., Murakami, T., Tangoku, A., Hayashi, H., Adachi, J., Suzuki, T. Archives of surgery (Chicago, Ill. : 1960) (1994)
- Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Akgun, H., Lechago, J., Younes, M. Anticancer Res. (2002)
- Comparison of initial distribution volume of glucose and intrathoracic blood volume during hemodynamically unstable States early after esophagectomy. Ishihara, H., Nakamura, H., Okawa, H., Yatsu, Y., Tsubo, T., Hirota, K. Chest (2005)
- Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF. Hübel, K., Mansmann, G., Schäfer, H., Oberhäuser, F., Diehl, V., Engert, A. Cytokine (2000)
- Marked and prolonged depression of factor XIII after esophageal resection. Saito, H., Fukushima, R., Kobori, O., Kawano, N., Muto, T., Morioka, Y. Surgery today. (1992)
- The effects of dopamine infusion on the postoperative energy expenditure, metabolism, and catecholamine levels of patients after esophagectomy. Nakagawa, M., Shinozawa, Y., Ando, N., Aikawa, N., Kitajima, M. Surgery today. (1994)
- Why does sucralfate improve healing in reflux esophagitis? The role of sucrose octasulfate. Orlando, R.C., Tobey, N.A. Scand. J. Gastroenterol. Suppl. (1990)
- Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging. Mizowaki, T., Nishimura, Y., Shimada, Y., Nakano, Y., Imamura, M., Konishi, J., Hiraoka, M. Int. J. Radiat. Oncol. Biol. Phys. (1996)
- Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy. Schäfer, H., Hübel, K., Bohlen, H., Mansmann, G., Hegener, K., Richarz, B., Oberhäuser, F., Wassmer, G., Hölscher, A.H., Pichlmaier, H., Diehl, V., Engert, A. Ann. Hematol. (2000)
- Monoclonal origin of an esophageal carcinosarcoma producing granulocyte-colony stimulating factor: a case report. Ota, S., Kato, A., Kobayashi, H., Yonezumi, M., Yamaguchi, J., Musashi, M., Imamura, M., Asaka, M. Cancer (1998)
- Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Sakamoto, K., Arakawa, H., Mita, S., Ishiko, T., Ikei, S., Egami, H., Hisano, S., Ogawa, M. Cytokine (1994)
- Changes in immune function following surgery for esophageal carcinoma. Tashiro, T., Yamamori, H., Takagi, K., Hayashi, N., Furukawa, K., Nitta, H., Toyoda, Y., Sano, W., Itabashi, T., Nishiya, K., Hirano, J., Nakajima, N. Nutrition (Burbank, Los Angeles County, Calif.) (1999)
- Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Oberg, S., Johansson, J., Wenner, J., Walther, B. Ann. Surg. (2002)
- Clinical relevance of L-carnitine-supplemented total parenteral nutrition in postoperative trauma. Metabolic effects of continuous or acute carnitine administration with special reference to fat oxidation and nitrogen utilization. Pichard, C., Roulet, M., Schutz, Y., Rössle, C., Chiolero, R., Temler, E., Schindler, C., Zurlo, F., Fürst, P., Jéquier, E. Am. J. Clin. Nutr. (1989)
- Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas. Horii, N., Nishimura, Y., Okuno, Y., Kanamori, S., Hiraoka, M., Shimada, Y., Imamura, M. Int. J. Radiat. Oncol. Biol. Phys. (2001)
- Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus. Younes, M., Lechago, J., Ertan, A., Finnie, D., Younes, A. Hum. Pathol. (2000)
- Epidural and intravenous fentanyl produce equivalent effects during major surgery. Guinard, J.P., Carpenter, R.L., Chassot, P.G. Anesthesiology (1995)
- Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. van Sandick, J.W., Gisbertz, S.S., ten Berge, I.J., Boermeester, M.A., van der Pouw Kraan, T.C., Out, T.A., Obertop, H., van Lanschot, J.J. Ann. Surg. (2003)
- Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Saad, R.S., El-Gohary, Y., Memari, E., Liu, Y.L., Silverman, J.F. Hum. Pathol. (2005)
- Serum interleukin-6, interleukin-8, hepatocyte growth factor, and nitric oxide changes during thoracic surgery. Yamada, T., Hisanaga, M., Nakajima, Y., Kanehiro, H., Watanabe, A., Ohyama, T., Nishio, K., Sho, M., Nagao, M., Harada, A., Matsushima, K., Nakano, H. World journal of surgery. (1998)
- Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma. Nakamura, T., Ide, H., Eguchi, R., Hayashi, K., Takasaki, K. Hepatogastroenterology (2003)
- The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Lee, J.M., Shun, C.T., Wu, M.T., Chen, Y.Y., Yang, S.Y., Hung, H.I., Chen, J.S., Hsu, H.H., Huang, P.M., Kuo, S.W., Lee, Y.C. Mutat. Res. (2006)
- Pharmacokinetic assessment of an oligopeptide-based enteral formula in abdominal surgery patients. Ziegler, F., Nitenberg, G., Coudray-Lucas, C., Lasser, P., Giboudeau, J., Cynober, L. Am. J. Clin. Nutr. (1998)
- Optimal treatment for localized esophageal cancer still uncertain. Lord, R.V. Am. J. Gastroenterol. (2000)
- Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Hironaka, S., Ohtsu, A., Boku, N., Muto, M., Nagashima, F., Saito, H., Yoshida, S., Nishimura, M., Haruno, M., Ishikura, S., Ogino, T., Yamamoto, S., Ochiai, A. Int. J. Radiat. Oncol. Biol. Phys. (2003)
- Administration of epidural bupivacaine combined with epidural morphine after esophageal surgery. Terai, T., Yukioka, H., Fujimori, M. Surgery (1997)
- Prostaglandin E1 ameliorates decreased tracheal blood flow after esophagectomy and aggressive upper mediastinal lymphadenectomy for esophageal carcinoma. Hasegawa, S., Imamura, M., Shimada, Y., Kanda, Y., Wada, H., Hitomi, S., Mori, K. J. Am. Coll. Surg. (1996)